A MODEL FOR CHRONIC COMPLICATIONS OF HUMAN DIABETES OR END-STAGE RENAL DISEASE
In vivo
A MODEL FOR CHRONIC COMPLICATIONS OF HUMAN DIABETES OR END-STAGE RENAL DISEASE
Rat (1), mouse (2)
Depending on your compounds and objectives, NOD mouse (type 1 diabetes) and Zucker rat (type 2 diabetes) strains are also available. Please contact us for further information.
(1) Similar features with the human type 1 diabetes are reproduced.
(2) Most of the characteristic features of the human type 2 diabetes are present.
(1) Streptozotocin treatment causes complete pancreatic b-cell necrosis leading to the absence of insulin secretion.
(2) This mouse strain is characterized by a lack of leptin signaling that induces hyperphagia and hyperinsulinemia.
Reference substances: angiotensin-converting enzyme inhibitors, AT1 receptor antagonists.